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Genome-wide meta-analysis identifies
novel loci associated with parathyroid
hormone level
Antonela Matana1, Dubravka Brdar2, Vesela Torlak2, Thibaud Boutin3, Marijana Popović1, Ivana Gunjača1,
Ivana Kolčić4, Vesna Boraska Perica1, Ante Punda2, Ozren Polašek4, Maja Barbalić1, Caroline Hayward3
and Tatijana Zemunik1*
Abstract
Background: Parathyroid hormone (PTH) is one of the principal regulators of calcium homeostasis. Although serum
PTH level is mostly accounted by genetic factors, genetic background underlying PTH level is insufficiently known.
Therefore, the aim of this study was to identify novel genetic variants associated with PTH levels.
Methods: We performed GWAS meta-analysis within two genetically isolated Croatian populations followed by
replication analysis in a Croatian mainland population and we also combined results across all three analyzed
populations. The analyses included 2596 individuals. A total of 7,411,206 variants, imputed using the 1000 Genomes
reference panel, were analysed for the association. In addition, a sex-specific GWAS meta-analyses were performed.
Results: Polymorphisms with the lowest P-values were located on chromosome 4 approximately 84 kb of the 5′ of
RASGEF1B gene. The most significant SNP was rs11099476 (P = 1.15 × 10−8). Sex-specific analysis identified genome-
wide significant association of the variant rs77178854, located within DPP10 gene in females only (P = 2.21 × 10− 9).
There were no genome-wide significant findings in the meta-analysis of males.
Conclusions: We identified two biologically plausible novel loci associated with PTH levels, providing us with
further insights into the genetics of this complex trait.
Keywords: Parathyroid hormone, Genome-wide association analysis, Meta-analysis
Background
Parathyroid hormone (PTH) plays a critical role in the
regulation of bone mineral metabolism and calcium
homeostasis (DeLuca, 1986). PTH regulates serum cal-
cium levels by stimulating osteoclast activity within bone
in order to release calcium. Circulating PTH enhances
the reabsorption of calcium in distal nephrons and in-
duces the synthesis of the vitamin D active metabolite
1,25-dihydroxyvitamin D (1,25(OH)2D3) within the kid-
ney (Kumar & Thompson, 2011; Kumar et al., 1991;
Khundmiri et al., 2016). The 1,25(OH)2D3 stimulates in-
testinal calcium absorption and moreover, has a syner-
gistic effect with PTH in bone resorption by stimulating
proliferation of osteoclasts (Kumar & Thompson, 2011;
Kumar et al., 1991; Khundmiri et al., 2016).
Variations in PTH synthesis and secretion are regu-
lated by serum levels of calcium and phosphate, as well
as by 1,25(OH)2D3 (Kumar & Thompson, 2011; Gago
et al., 2005). Decreases in serum levels of calcium and
increases in serum levels of phosphate stimulate the se-
cretion of PTH, while 1,25(OH)2D3 decreases PTH se-
cretion (Silver & Levi, 2005). Regulation of PTH
secretion in response to variations in serum calcium is
mediated by the calcium-sensing receptors on the mem-
brane of parathyroid cells (Kumar & Thompson, 2011;
Brent et al., 1988). 1,25(OH)2D3 associates with the vita-
min D receptor and thus represses the transcription of
PTH. The secretion of PTH is also indirectly altered by
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1,25(OH)2D3 and its regulation of calcium-sensing re-
ceptor expression (Kumar & Thompson, 2011). Serum
phosphate regulates PTH mRNA and serum PTH levels
independently of changes in either serum calcium or
1,25(OH)2D3 levels (Kilav et al., 1995).
The most common pathological condition of excessive
secretion of parathyroid hormone is hyperparathyroidism.
Primary hyperparathyroidism is due to hypersecretion of
the parathyroid gland, while secondary hyperparathyroid-
ism can result from conditions that lead to hypocalcemia,
especially observed in patients with chronic kidney disease
(Fraser, 2009). Hypoparathyroidism, parathyroid hormone
deficiency, is an uncommon condition that occurs mostly
due to surgical removal of the parathyroid gland (Abate &
Clarke, 2017).
Both environmental and genetic factors influence
serum PTH levels. It is estimated that 60% of the vari-
ation in PTH concentrations is genetically determined.
(Hunter et al., 2001). However, the genetic background
underlying PTH level is not yet well understood.
Only one high-density genome-wide association study
(GWAS) of PTH concentration has been reported to
date (Robinson-Cohen et al., 2017). Robinson-Cohen et
al. identified five significantly associated loci, including
the strongest associated SNP rs6127099 located up-
stream of CYP24A1, a gene that encodes the primary
catabolic enzyme for 1.25 (OH)2D (Robinson-Cohen et
al., 2017). The other significantly associated loci were in-
tronic variant rs4074995 within RGS14 (regulator of G-
protein signaling 14), rs219779 adjacent to CLDN14
(Claudin 14), rs4443100 located near RTDR1 (RSPH14,
radial spoke head 14 homolog) and rs73186030 located
near CASR (calcium-sensing receptor) gene (Robinson-
Cohen et al., 2017). However, only three of these five loci
(rs6127099, rs4074995 and rs219779) were replicated
within an independent sample. Altogether, the five re-
ported loci explained only 4.2% of the variance in circu-
lating PTH, suggesting that additional genetic variants
remain undiscovered.
The aim of our study is identification of novel loci as-
sociated with the parathyroid function, by performing a
GWAS meta-analysis of plasma PTH levels within two
genetically isolated Croatian populations (Korcula and
Vis) following by replication analysis in the urban popu-
lation of Split. To maximize the power of the study, we
additionally performed meta-analysis for PTH plasma
levels in all three Croatian populations. We also con-
ducted gender-specific GWAS meta-analyses.
Methods
Study cohorts
This study was performed on samples from three
Croatian populations: from the Dalmatian islands of
Korcula and Vis and the mainland city of Split, within
the large-scale project of “10,001 Dalmatians” (Rudan
et al., 2009). A detailed description of the cohorts is
provided in Table 1. The Korcula population is genet-
ically isolated from Croatian Mainland, while Vis
population is genetically isolated from Croatian Main-
land and surrounding islands (Vitart et al., 2008). For
all study populations, we excluded participants who
underwent parathyroid surgery, as well as individuals
who had PTH level < 5 pg/ml, which is near the mini-
mum PTH assay detection limit (4.3 pg/ml). After
these exclusions, the number of individuals available
with PTH level and genotype data was 806 in Kor-
cula, 831 in Vis and 959 in Split. In all three cohorts
there were no participants who reported serious renal
disease that could affect PTH concentration. The
study was approved by the Research Ethics Commit-
tees in Croatia and Scotland and all participants pro-
vided informed consent. All analyses were in
accordance with the relevant guidelines and
regulations.
Genotyping and imputation
Additional file 1: Table S1 shows cohort-summary infor-
mation on genotyping, imputation and quality control
procedures. The final numbers of single nucleotide poly-
morphisms (SNPs) included in analyses were 9,182,797
for the Korcula sample, 8,865,173 for the Vis sample and
8,777,560 for the Split sample. The number of overlap-
ping SNPs present in all three cohorts was 7,411,206.
Table 1 Characteristics of study participants
Variables Korcula Vis Split
N with PTH and GWAS data 863 834 960
N underwent parathyroid surgery 1 0 1
N with PTH level < 5 pg/ml 56 3 3
Sample size used in the analyses 806 831 959
Women, N (%) 524 (65%) 486 (58%) 586 (61%)
Median age, (qL,qU) 57 (47, 67) 57 (45,69) 52 (40, 61)
Median PTH, pg/ml (qL,qU) 19.9 (13.7, 29.1) 25.9 (18.4, 32.1) 21.6 (17.2, 26.5)
N: number of individuals; qL: lower quartile, qu: upper quartile
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Measurement of PTH
Plasma PTH levels were determined by radio-
immunoassay method (RIA) in the Laboratory of Bio-
chemistry, Department of Nuclear Medicine, University
Hospital Split. RIA ran on the Scintillation counter li-
quid samples, Capintec, and 125I served as a marker.
The concentrations of PTH in the plasma were deter-
mined using commercial kits (DIAsource hPTH
-120 min-IRMA Kit, DIAsource ImmunoAssays S.A,
Belgium). The reference range of plasma PTH levels is
12.26–35.50 pg/ml.
Statistical analyses
We performed genome-wide association analysis within
each data set and then conducted a meta-analysis of two
genetically isolated cohorts (Korcula and Vis) followed
by replication analysis in the cohort of the mainland city
of Split. To maximize the study power, we also per-
formed a further meta-analysis of all three cohorts.
Genome-wide association analyses
Association analysis for the Split sample was carried out
using a combination of R-package GenABEL and
SNPTEST software, while for the Korcula and Vis
samples analyses were conducted using R-packages
GenABEL and VariABEL (Aulchenko et al., 2007;
Marchini et al., 2007; Struchalin et al., 2012).
PTH levels were adjusted for age and sex using linear
regression analysis and the calculated residuals were
inverse-Gaussian transformed to achieve a normal distri-
bution. GWAS was performed on transformed residuals
using linear mixed model which accounts for population
structure and relatedness. Association statistics for each
SNP, including effect size estimates (β-estimates), stand-
ard errors and p-values were calculated under an addi-
tive genetic model.
Prior to performing the meta-analysis we calculated
genomic inflation factors (lambdas) in individual data
sets. No adjustments were necessary (λKorcula = 1.026,
λVis = 1.001, λSplit = 0.99).
Meta-analysis
Meta-analysis was carried out using the R-package
MetABEL (R: A Language and Environment for Statis-
tical Computing, 2018). Meta-analysis was conducted
using the inverse-variance fixed-effects method on over-
lapping SNPs based on the β-estimates and standard er-
rors from each study. Meta-analyses showed no significant
evidence for inflated statistics (both λKorcula − Vis and
λKorcula − Vis − Split were 1.01), thus no genomic correc-
tion was applied. To visualize results of the meta-
analysis, Manhattan and quantile-quantile (QQ) plots
were created using R-package qqman (Turner, 2014).
Regional association plots for loci of interest
(±400 kb) were produced using Locus Zoom based on
hg19 genome build and 1000 genomes EUR popula-
tion as the linkage disequilibrium (LD) population
(Pruim et al., 2010). Forest plots for the most associ-
ated SNP were created using R-package MetABEL. To
confirm the genotyping quality for the most associ-
ated SNPs in the regions, cluster plots were visually
inspected using the Illumina GenomeStudio software
package. If the SNP of interest was not directly geno-
typed, but imputed, then cluster plots were examined
for directly genotyped SNPs in high LD with the SNP
of interest (r2 > 0.8), located on the same chromosome
and less than 400 kb apart. A genome-wide significance of
association was defined as p − value ≤ 5 × 10−8. Power
calculations were performed using Quanto version 1.2.4
for quantitative traits (WJ MJ, 2006).
Sex-specific analyses
In order to identify sex-specific effects we performed
GWAS analyzing males and females separately in each
cohort. We used the same procedures as in the primary
analyses with the exception of the gender covariate. As-
sociation results were meta-analyzed using the inverse-
variance fixed-effects method. The total sample sizes
were 1596 in women and 1000 in men.
Results
Meta-analyses
In each population, a separate genome-wide associ-
ation study of PTH levels was conducted. We meta-
analyzed two genetically isolated cohorts, Korcula and
Vis (Additional file 1: Figure S1), and then replicated
results in the Split population. A total of 1637 indi-
viduals were included in the meta-analysis and 959 in
the replication analysis (Table 1). The most associated
SNP was rs4616742 (reference allele C, β = 0.18, SE =
0.04, P = 4.42 × 10−7). The SNP is located near protein
coding gene RASGEF1B (RASGEF Domain Family
Member 1B). All top SNPs, located on the
chromosome 4 near RASGEF1B gene with P < 10−6
from meta-analysis of ‘genetically isolated populations’
reached P < 0.05 in the Split population.
To maximize the study power, we performed a meta-
analysis of all three cohorts. In total, 2596 individuals
were included in the meta-analysis (Table 1). The results
are shown in Fig. 1a. As seen from the quantile-quantile
plot there was no early deviation from expected P values
(Fig. 1b). Four SNPs, representing one locus, reached
genome-wide significance. As in the meta-analysis of
two genetically isolated cohorts, SNPs with the lowest P-
values were located on chromosome 4 near RASGEF1B.
The most associated SNP was rs11099476 (P = 1.15 ×
10−8), which explained 1.14% of the variance in PTH.
We found the T allele of the rs11099476 to be associated
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with higher PTH level (β = 0.16, SE = 0.03). Effect sizes
were in the same direction across all three cohorts (Fig. 1c).
The regional association plot for rs11099476 is given in
Fig. 2a. The identified SNP, rs11099476, is in high LD
with the top SNP from meta-analysis of ‘genetically
isolated populations’, rs4616742 (r2 = 0.9). These
results indicated that associated locus is becoming
more significant as the sample size increases and
confirmed the consistency of our top finding.
Analysis also revealed several suggestive loci (P < 5 ×
10−6), including rs77178854 in the DPP10 gene (P = 2.
46 × 10−7), rs481121 near the GRIK3 gene (P = 3.58 ×
10−7), rs76615278 in the FKBP8 gene (P = 6.34 × 10−7),
rs1875872 near the ASIC2 gene (P = 1.94 × 10−6),
rs9512841 near the GSX1 gene (P = 2.01 × 10−6),
rs191686630 in the PDE4D gene, rs3136797 in the
POLB gene (P = 2.68 × 10−6), rs499177 near the MTDH
gene and rs58726672 near the GATA3 gene (P = 4.77 ×
10−6) (Table 2).
Sex-specific analyses
We searched for gender-specific loci by performing
sex-specific GWAS meta-analysis, analyzing females
and males separately in each cohort. The results for
females are shown in Fig. 3. The top hit detected in
the meta-analysis of all three cohorts, rs77178854, lo-
cated within DPP10 gene, reached genome-wide sig-
nificance (reference allele C, β = 0.82, SE = 0.14, P = 2.
21 × 10−9) in females (Table 3). Effect sizes were in
the same direction across all three cohorts (Fig. 3c).
Regional association plot of the identified SNP is
shown in Fig. 2b. No single locus reaching genome
wide significance was identified in males (Additional
file 1: Table S2).
Discussion
In this GWAS meta-analysis of three Croatian popula-
tions we identified a novel genome-wide significant locus
associated with plasma PTH level near gene RASGEF1B
on chromosome 4. We also identified a sex-specific sig-
nificant association in females in the DPP10 gene.
The significance of the identified polymorphism
rs11099476 was most influenced by the Vis population,
which is isolated from the Croatian Mainland and sur-
rounding islands, then by the Korcula population which
is isolated from the Croatian Mainland and the least
contributed by the mainland city of Split population
(Fig. 2c). However, although the locus significance was
most affected by the isolated populations, significance
has been amplified in the meta-analysis of all three co-
horts compared to meta-analysis of ‘genetically isolated
populations’.
The identified common variant rs11099476 accounts
for 1.14% of population variance in plasma PTH. RAS-
GEF1B is the guanine nucleotide exchange factor with
specificity for Rap2A, a member of Rap subfamily of
Ras-like G proteins (Yaman et al., 2009). Rap2 subfamily
contains Rap2A and Rap2B, which share about 90% se-
quence homology (Paganini et al., 2006). Rap2A protein
binds GDP to GTP and exhibits a low intrinsic GTPase
activity in the presence of Mg2+ (Lerosey et al., 1991),
while Rap2B increases intracellular calcium level and
phosphorylation level of extracellular signal-related kin-
ase (ERK) 1/2 (Di et al., 2015). Variations near RAS-
GEF1B gene have been associated with height (He et al.,
2015; Allen et al., 2010). Height is positively correlated
with calcium absorption efficiency which is important
determinant of calcium balance (Abrams et al., 2005).
Some evidence of association was also found for varia-
tions in this gene and bone density, hip, and cystatin C
Fig. 1 a Manhattan plot of SNPs for PTH levels in the meta-analysis of three cohorts. The y axis shows the −log10 P values of 7,411,206 SNPs, and
the x axis shows their chromosomal positions. The blue line indicates the threshold for suggestive hits (P = 5 × 10−5), and the red line represents
the threshold for genome-wide significance (P = 5 × 10−8). b Quantile-quantile plot in the meta-analysis of three cohorts. c Forest plot of rs11099476
effect estimates in individual populations and the combined meta-analysis
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in serum (Kiel et al., 2007; Kottgen et al., 2010). PTH is
a significant negative predictor of bone mineral density
at the hip (Sneve et al., 2008). Cystatin C in serum is a
biomarker of kidney function, and chronic kidney dis-
ease (Kottgen et al., 2010). Disturbed kidney function
can influence PTH stimulated calcium reabsorption and
synthesis of 1,25(OH)2D3 (Kumar & Thompson, 2011;
Kumar et al., 1991; Khundmiri et al., 2016). However, to
understand the mechanism underlying the observed
association further functional studies of RASGEF1B will
be needed.
Although no signals other than rs11099476 reached
genome-wide significance, several candidate loci showed
suggestive evidence of association. Particularly interesting
is the variant near GATA3 gene since mutations in this
gene are the cause of hypoparathyroidism with sensori-
neural deafness and renal dysplasia (Van Esch et al., 2000).
Of note, in a previous large GWA meta-analysis, variant
Fig. 2 a Regional association plot for the chromosome 4 locus rs11099476 in the meta-analysis of three cohorts. b Regional association plot for
the chromosome 2 locus rs77178854 in the sex-stratified meta-analysis of three cohorts among females. SNPs are plotted by position against association
with PTH (−log10 P values). The purple diamond highlights the most significant, whereas the colors of other variant represent LD with most significant SNP
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near GATA3 gene was found to be associated with serum
calcium (O'Seaghdha et al., 2013).
Given the reported differences in PTH level be-
tween males and females, we performed sex-specific
analyses (Wei et al., 2015; Serdar et al., 2017). Our
study supports the sex-specificity underlying PTH
level. Sex-stratified analysis in women identified a
novel locus associated with PTH. The identified locus
is the intron variant rs77178854, located within
DPP10 gene. DPP10 encodes a membrane protein
that is a member of the serine proteases family,
which binds specific voltage-gated potassium channels
and alters their expression and biophysical properties.
It is highly expressed in brain, pancreas, spinal cord
and adrenal gland (Allen et al., 2003), and may serve
as a prognostic marker in colorectal cancer (Park et
al., 2013). It is interesting to note that Aigner et al.
showed that high serum PTH concentrations were
associated with distal colorectal cancer in women but
not in men (Aigner et al., 2015). The existence of
DPP10 in endocrine cells indicate that the protein
might also have an additional role in the regulation
of hormone secretion (Bezerra et al., 2015), which
also supports our finding. Further studies of DPP10
will be needed to clarify this result.
The only previously published high-density GWAS
for PTH levels did not identify RASGEF1B or DPP10
at a genome-wide significant level, despite having a
sample size of over 29,155 participants (22, 653 in
discovery stage and 6502 in replication analysis)
(Robinson-Cohen et al., 2017). The possible explan-
ation could be an increased relative effect of these
loci in our populations due to the reduced genetic
and environmental heterogeneity found in two out of
three cohorts (i.e., Korcula and Vis) (Rudan et al., 2008)
compared to the urban populations used in the
Table 2 Associations of top single nucleotide polymorphisms(P < 5 × 10−6) with PTH concentrations
SNP Chr Position Nearest Gene Effect Allele Other Allele EAF Korcula EAF Vis EAF Split GnomAD EAF β SE P value
rs11099476 4 82,486,056 RASGEF1B T A 0.57 0.55 0.54 0.59 0.16 0.03 1.15×10−8
rs77178854 2 116,496,539 DPP10 C G 0.97 0.98 0.99 0.98 0.58 0.11 2.46×10−7
rs481121 1 37,203,485 GRIK1 A G 0.56 0.56 0.58 0.49 0.14 0.03 3.58×10−7
rs76615278 19 18,654,588 FKBP8 G A 0.84 0.83 0.82 * 0.20 0.04 6.34×10−7
rs1875872 17 31,795,716 ASIC2 A G 0.62 0.65 0.65 0.65 0.14 0.03 1.94×10−6
rs9512841 13 28,309,646 GSX1 G A 0.51 0.52 0.53 0.58 0.13 0.03 2.01×10− 6
rs191686630 5 58,477,398 PDE4D A T 0.11 0.16 0.21 * 0.19 0.04 2.36×10−6
rs3136797 8 42,226,805 POLB C G 0.98 0.99 0.98 0.99 0.57 0.12 2.68×10−6
rs499177 8 98,472,201 MTDH T C 0.46 0.57 0.45 0.44 0.13 0.03 4.66×10−6
rs58726672 10 8,407,822 GATA3 C T 0.98 0.98 0.98 0.98 0.57 0.13 4.77×10−6
Top SNPs were defined as the SNP with lowest P value within a 500 kb window
Chr: chromosome; EAF: effect allele frequency; GnomAD EAF: effect allele frequency from Genome Aggregation Database; β: effect size; SE: standard error
*variants without frequency information in Genome Aggregation Database
Fig. 3 a Manhattan plot of SNPs for PTH levels in the sex-stratified meta-analysis of three cohorts among females. The y axis shows the −log10 P
values of 7,411,206 SNPs, and the x axis shows their chromosomal positions. The blue line indicates threshold for suggestive hits (P = 5 × 10−5),
and red line represents the threshold for genome-wide significance (P = 5 × 10−8). b Quantile-quantile plot in the sex-stratified meta-analysis of
three cohorts among females. c Forest plot of rs77178854 effect estimates in individual populations and the combined meta-analysis among females
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analysis of Robinson-Cohen et al. (Robinson-Cohen et
al., 2017). Previously reported CYP24A1, RGS14 and
CLDN14 variants associated with PTH level (Robin-
son-Cohen et al., 2017) had the same directions of ef-
fect in our study as originally reported but did not
show significant associations, probably due to limited
sample size of our study or specificity of isolated pop-
ulations (Additional file 1: Table S3).
The greatest strengths of our study include a com-
prehensive set of genetic variants examined and eth-
nically homogeneous sample. We had sufficient data
to confidently detect an association for the identified
RASGEF1B locus, since our meta-analysis had 92%
power to detect associated SNP with an effect size of
0.19 and minor allele frequency of 0.45 at the
genome-wide level of significance. Furthermore, meta-
analysis performed in females only had 86% power to
detect DPP10 locus with an effect size of 0.82 and
minor allele frequency of 0.02 at the genome-wide
level of significance. Meta-analysis performed in males
only had 84% power to detect SNPs with an effect
size of 0.35 and minor allele frequency of 0.3 at the
genome-wide level of significance. The main limita-
tion of our study is the modest sample size used in
the analysis, reducing statistical power for detecting
additional associations with smaller effect sizes or
minor allele frequencies. Nevertheless, we have identi-
fied novel, previously unsuspected and biological
plausible associations with PTH variation. Further
replication analysis would be required to confirm our
findings and to discover additional genetic variants
underlying PTH levels in order to explain more of
the variability in PTH variations.
Conclusions
In summary, in a GWA meta-analysis of PTH levels we
identified a novel significant locus rs11099476 located
near a guanine nucleotide exchange factor RASGEF1B.
The finding appears to be consistent based on analyses
of meta-GWAS across all three analyzed cohorts and
meta-GWAS across two isolated populations followed
by replication analysis in the mainland cohort. Our work
also includes the first gender-specific GWAS performed
to date and revealed significant association for an intron
variant rs77178854 located within the DPP10 gene in
women, indicating the possibility that sex-specificity is
underlying PTH level. To conclude, findings from this
study improve the current knowledge of the genetic fac-
tors regulating PTH levels and their validation in inde-
pendent populations would be beneficial.
Additional file
Additional file 1: Supporting Information. (XLSX 54 kb)
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Chr: chromosome; EAF: effect allele frequency; GnomAD EAF: effect allele frequency from Genome Aggregation Database; β: effect size; SE: standard error
*variants without frequency information in Genome Aggregation Database
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